The kidney is the limiting organ to this therapy since proximal tubular cells intake radiolabeled somatostatin[5] causing acute kidney injury, and ultimately end stage renal disease.[6,7] In proximal tubular cells, the megalin-receptor plays a central role in receptor-mediated endocytosis of somatostatin as well amino acids.[8,9]. Here, SST is linked to chronic kidney disease.